Gliclazide 60 mg MR Tablet – Brands in India, Manufacturer & PCD Franchise (Glizest-60)
Gliclazide 60 mg Modified Release Tablets Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Second-generation sulphonylurea (Gliclazide-based)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Gliclazide 60 mg Modified Release Tablets Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Gliclazide 60 mg Modified Release Tablets Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Gliclazide 60 mg Modified Release Tablets Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Gliclazide 60 mg Modified Release Tablets formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the general range products product list. No franchise fee; minimum first order ₹25,000 – cost and documents.
Gliclazide 60 mg MR Brands in India – Glizest-60 for PCD Franchise & Wholesale
Looking for gliclazide 60 mg mr brands in India? Trumac Healthcare markets gliclazide 60 mg mr as Glizest-60, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock across India. Gliclazide MR is the sulfonylurea physicians prefer for its once-daily dosing and lower hypoglycaemia risk.
It is part of the cardiac-diabetic PCD franchise (Ecron Life Sciences) range. Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners; no franchise fee, minimum first order ₹25,000.
Related brands
- Glizest-60 – gliclazide 60 mg MR, 4 x 5 x 10
- Glizest-M 60/500 – gliclazide + metformin
- Glizest-MV – gliclazide + metformin + voglibose
- Full range: cardiac-diabetic PCD franchise (Ecron Life Sciences)
Ways to work with us
- PCD pharma franchise – gliclazide 60 mg mr under our brand on a monopoly basis for your area, with visual aids and promotional material
- Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
- Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation
How to start
- Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
- Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
- Confirm the order and pay by NEFT, RTGS or IMPS
- Goods are dispatched once payment reflects, with the docket number for tracking
Questions buyers ask
Which gliclazide 60 mg mr brands are available in India for PCD franchise?
Glizest-60 from Trumac Healthcare, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis across India.
Do you supply gliclazide 60 mg mr wholesale?
Yes, to distributors and stockists with a valid drug licence. Share quantity and location for the rate.
Which division is it part of?
The cardiac-diabetic (Ecron Life Sciences) division, which can be taken alone on monopoly for your district.
Can I get gliclazide 60 mg mr under my own brand?
Share your brand name, pack and quantity on WhatsApp and we will confirm availability and send a quotation.
Enquiry: Share your gliclazide 60 mg mr requirement – franchise or wholesale, with strength, quantity and location. WhatsApp +91 90416 77932.
Therapeutic Indications
- Type-2 diabetes mellitus
- Adjunct to metformin
- Diabetic patients with vascular risk (gliclazide's antioxidant benefit)
Mechanism of Action
Gliclazide is a second-generation sulphonylurea that stimulates pancreatic beta-cell insulin secretion by closing ATP-sensitive K+ channels (SUR1). It also has antioxidant and antiplatelet effects via free-radical scavenging and reduced platelet aggregation — providing additional benefit in diabetic vascular complications.
Dosage & Administration
- Adults: 1 tablet once daily before breakfast (or as advised)
- Titrate based on glycaemic response
- Maximum 320 mg/day total gliclazide
- MR tablets: swallow whole, do not crush
Side Effects
- Hypoglycaemia
- Weight gain (mild)
- GI upset
- Skin reactions (rare)
- Cholestatic jaundice (rare)
Contraindications
- Type-1 diabetes
- Diabetic ketoacidosis
- Severe hepatic/renal impairment
- Pregnancy and breastfeeding
- Sulphonamide hypersensitivity
Storage
Store below 25°C.
PCD Pharma Franchise for Gliclazide 60 mg Modified Release Tablets Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 4 x 5 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Gliclazide 60 mg Modified Release Tablets Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Gliclazide 60 mg Modified Release Tablets Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Gliclazide 60 mg Modified Release Tablets Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Gliclazide 60 mg Modified Release Tablets Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Gliclazide 60 mg Modified Release Tablets Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Gliclazide 60 mg Modified Release Tablets Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Gliclazide 60 mg Modified Release Tablets Tablet?
Available pack sizes include: 4 x 5 x 10 (Blister).
What is the MRP / trade price for Gliclazide 60 mg Modified Release Tablets Tablet?
MRPs range from ₹1100 to ₹1100 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Gliclazide 60 mg Modified Release Tablets Tablet?